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Numerous changes continue to occur in cochlear implant candidacy. In general, these have been accompanied by concomitant
and satisfactory changes in surgical techniques. Together, this has advanced the utility and safety of cochlear implantation. Most
devices are now approved for use in patients with severe to profound unilateral hearing loss rather then the prior requirement
of a bilateral profound loss. Furthermore, studies have begun utilizing short electrode arrays for shallow insertion in patients
with considerable low-frequency residual hearing. This technique will allow the recipient to continue to use acoustically ampliﬁed
hearing for the low frequencies simultaneously with a cochlear implant for the high frequencies. The advances in design of, and
indications for, cochlear implants have been matched by improvements in surgical techniques and decrease in complications.
The resulting improvements in safety and eﬃcacy have further encouraged the use of these devices. This paper will review the
new concepts in the candidacy of cochlear implant. Medline data base was used to search articles dealing with the following
topics: cochlear implant in younger children, cochlear implant and hearing preservation, cochlear implant for unilateral deafness
and tinnitus, genetic hearing loss and cochlear implant, bilateral cochlear implant, neuropathy and cochlear implant and neural
plasticity, and the selection of patients for cochlear implant.
1.Introduction
The ﬁrst pediatric cochlear implant program was established
at the House Ear Institute in 1980. Incredible as it may seem
from the current perspective, the primary issue in that era
was whether to consider implanting children at all. In 1980,
the ﬁrst child (a 9-year-old boy) was implanted, and by 1982,
12 children with age ranges from 3.5 to 17 years had been
implanted in their program [1, 2] The House/3M device
obtained Food and Drug Administration (FDA)approval for
implantation in adults in 1984 and in children in 1986. In
June 1990, the Nucleus-22 channel implant received FDA
approval for implantation in children aged 2 years and older.
Shortly thereafter, momentum gained rapidly, and by the
mid-1990s, more children were being implanted than adults
[2]. In the USA, the Food and Drug Administration, a con-
sumer protection and healthy agency, has historically had
great inﬂuence on cochlear implant candidacy.
NumerousclinicaltrialshavebeenconductedbytheFDA
since cochlear implants were ﬁrst introduced, and numerous
supplements have been submitted to the FDA as these de-
viceshaveundergonetechnologicalimprovements. Thus,the
determination of the implant candidacy is ultimately based
on the best knowledge and judgment of the managing phy-
sician. Changes in candidacy have primarily included im-
planting persons with increasing amounts of residual hear-
ing, implanting persons with increasing amounts of preop-
erative open-set speech skills, implanting children at young-
er ages, and implanting greater numbers of persons with
abnormal cochleae.
Theprimaryreasonthatselectioncriteriahavechangedis
thatpatientswithimplantsare obtainingincreasing amounts
of open-set word recognition with the available devises.
Although this increased performance is largely due to the
technologicaladvancementsthathaveoccurredintheﬁeld,it
may also due to, at least in part, to the fact that patients with2 International Journal of Otolaryngology
greater amounts of residual hearing and greater amounts of
residual word recognition skills are receiving cochlear im-
plants.
The candidacy requirements for pediatric, and adult,
cochlear implantation have gradually loosened. The obvious
goal is to never have a single patient perform more poorly
with their cochlear implant than they previously performed
with hearing aids alone [2–4]. Thus, with each relaxation in
requirements, a waiting period is required to accumulate the
data to demonstrate the degree of beneﬁt obtained by im-
planting these patients with higher degrees of residual hear-
ing [2]. To date, the most consistent ﬁnding is that patients
with greater degrees of residual hearing preoperatively per-
format higher levelswith cochlearimplants. In children, this
situation is even more complex because of greater diﬃculty
and reduced reliability of audiologic testing in very young
children. Slowly though, the data that have accumulated
support the implantation of patients at increasingly younger
ages and in those patients with higher degrees of residual
hearing. The indications for cochlear implantation have ex-
panded, as many unilaterally implanted individuals are able
to achieve open-set word recognition. Despite the beneﬁts
seen in unilateral implantation, many individuals have
diﬃculty perceiving speech in noisy environments. Bilateral
cochlear implantation has made great strides in providing
individuals access to sound information from both ears,
allowing improved speech perception in quiet and in noise,
as well as sound localization. The purpose of this paper is
to review the literature searching for the new concepts in
the indication and selection of patients to cochlear implant.
The following sections will deal with these new concepts
separately.
2.CochlearImplant inYoungerChildren
Widespread universal newborn hearing screening has led to
increased identiﬁcation of infants with hearing loss world-
wide [5–7]. This increase in early diagnosis has led to great-
er opportunities for early intervention [6]. There is now
abundant evidence that early implantation in children is ad-
vantageous [2, 4–6]. Language development in children be-
gins to occur from birth and is nearly complete by the age
of6 years. Language skills, speech quality,and expressive and
receptive vocabulary are enhanced by exposure to aural lan-
guagefrom as early an age as possible. Datafrom Kilenyet al.
implant program clearly demonstrated that children im-
planted between the ages of12 and 36 months outperformed
children implanted between the ages of 37 and 60 months
[5]. This, together with earlier identiﬁcation of childhood
deafness, is pushing the age at implantation lower.
For many years, the lower limit for age at implantation
was 2 years. The ﬁrst clinical trial to evaluate a multichannel
implant in children was the Nucleus 22 device. The candi-
dacyguidelinesforthistrialindicatedappropriatecandidates
could be as young as 2 years of age. The ﬁrst clinical trial to
include children less than 2 years of age was with the Clarion
device. The Clarion device could be indicated for children of
18 months if the Rx demonstrated ossiﬁcation. All cochlear
implant devices can be safely indicated for children of 12
monthsand older.Asof2000,the FDAhas approveda device
forimplantation forthose patientsaged12monthsandolder
[4]. Although prior and ongoing research has attempted to
address the uniqueissues of safety, candidacy, programming,
and eﬃcacy in this very young age group, CI in children
younger than 12 months of age remains controversial
Further reductions in age at implantation are currently
limited bythenature ofaudiologictesting invery youngchil-
dren. In general, using modern techniques, a conﬁdent as-
sessment of severe to profound sensorineural hearing loss
c a nb em a d ei nac h i l db yt h et i m et h e ya r e1 2m o n t h so l d .
In cases of hereditary hearing loss or meningitis, a conﬁdent
assessment cansometimes bemadeatagesyoungerthanthis.
Some authors [5, 6] prefer to have children with probable
severe to profound hearing losses referred to their program
by the age of 6 months. In most cases this gives the program
time tocompletea thoroughassessment with conﬁdenceand
enables implantation at the age of approximately 12 months.
Inherent in the discussion of CI in children younger
than 12 months is the ability to reliably diagnose children
of this age group with bilateral profound deafness. With re-
spect to diagnosis of infant hearing loss, a paramount con-
cern is the issue of speciﬁcity: the risk of implanting a child
without profound deafness. CI evaluation of a child young-
er than 1 year of age should include the following: an at-
tempt at behavioral audiometry (i.e., VRA), bilateral OAEs,
ear-speciﬁc and frequency-speciﬁc ABR or ASSR, bilateral
tympanometry, and acoustic reﬂexes. Present OAEs with
abnormal ABR or ASSR and absent reﬂexes should generate
suspicionforAN/AD,andECoGcanbeusedasan additional
test in this setting [5–7].
Speech perception testing in this age group remains chal-
lenging as most tests are language based and not appropriate
for children younger than 1 year. use of the infant-toddler
meaningful auditory integration scale (IT-MAIS), a parental
survey of early speech development, has been employed reli-
ably in this age group as a proxy for speech perception and
linguistic development [3, 8]. This 10-question structured
interview assesses thethree categoriesofauditory-speciﬁc be-
havior, including vocalization, alerting to sound, and deriv-
ing meaning from sound [6, 8]. Parents score the frequency
of various behaviors on a 4-point scale from never (0)
to always (4). Normative is available for normal hearing
children throughoutthe ﬁrst yearof life and older, beginning
at 1 month old. The IT-MAIS survey can be administered
to parents of children with suspected hearing loss and com-
pared with age-speciﬁc norms in normal hearing infants.
Although used in a variety of research and settings, bab-
ble assessment is not currently a standard component of pre-
operative CI evaluation in children younger than 1 [6]. On
the other hand, anesthetic risk is an important consideration
for children younger than 1 year of age. Epidemiological
studies of anesthesia-related complications have found the
incidence of morbidity, mortality, and life-threatening ad-
verse eventsin children younger than 12 months tobe signif-
icantlyhigherthanchildrenolderthan1yearofage[6,9,10].
Although anesthetic concerns unique to very young
children exist, data in the CI literature support perioperative
safety intheunder-1population.Lesinski-Schiedat etal.[11]International Journal of Otolaryngology 3
reported no higher incidence of surgical complications in 27
children implanted under 1 year of age compared with older
toddlers. James and Papsin [12] in 2004 analyzed inpatient
records of 25 infants implanted between 7 and 12 months
of age and found no anesthetic or immediate postoperative
complications. More recent studies by Dettman et al. [13],
Valencia et al. [14], and Miyamoto et al. [15]r e p o r tn o
anesthetic orimmediate postoperative complicationsin chil-
dren younger than 12 months. Finally, in the largest series to
d a t e ,R o l a n de ta l .[ 16] reported no immediate perioperative
adverse events in 50 children implanted under 1 year of age.
Even though the anatomical aspects of the facial recess
and the cochlea are similar to olderchildren, several risks are
reported in the literature for cochlear implant in the younger
group. Intraoperative blood loss, facial nerve anatomy, re-
ceiver/stimulator ﬁxation, and device migration with skull
growth present unique risks to children younger than 1 year
[6]. Two sources of blood loss are important in very young
children: bone marrow and emissary veins. Pneumatization
of the mastoid bone increases with age, approaching 60% at
2 years of age. Very young children, therefore, have a greater
proportion of bone marrow in their mastoid and greater risk
of blood loss during mastoidectomy [6]. In addition, blood
loss from mastoid emissary veins can have a greater impact
onoverallcirculatingbloodvolumeinchildren youngerthan
1y e a ro fa g e .[ 6]
Long accepted as a standard in temporal bone surgery,
theuse offacial nerve monitoring in CI surgery isnearly uni-
versal. In children younger than 1 year, minimal inferior ex-
tension of the postauricular skin incision, careful identiﬁca-
tion of the facial nerve, and judicious use of intraoperative
facial nerve monitoring can assist with these surgical chal-
lenges.
Inveryyoungchildren,theposteriorscalpﬂapistypically
thinner and more delicate, necessitating constant care and
atraumatic handling of the skin ﬂap and soft tissues [6]. A
variety of device ﬁxation techniques have been advocated in
children, including creation of a bony well and suture tie-
downoruseofatightsoft tissuepocketwithoutwell oraddi-
tional ﬁxation [6].
The circumferential dural exposure for seating of the re-
ceiver/stimulatorispreferableforsomeautherssoastomini-
mize device proﬁle and damage from external trauma [17].
Others advocate that the device stability achieved with a
t i g h ts o f tt i s s u ep o c k e ti se q u i v a l e n tt ot h a ta c c o m p l i s h e db y
creation of a bony well while eliminating the risks of intra-
cranial complications [18].
Ongoing advances in receiver/stimulator design, such as
therecentlyintroducedNucleus5(CI512)seriesbyCochlear,
attempt to address these issues by creating a thinner device
contoured to the infant skull. The eﬀect of this change in de-
vicedesign is as yet unknown [6].Skull growthand electrode
migration are also a consideration in this very young pop-
ulation. Infant head circumference undergoes a dramatic
change in the ﬁrst year of life, especially as compared with
t h er a t eo fg r o w t ha f t e r1 2m o n t h so fa g e6 .A sm e n t i o n e d
previously, the cochlea is adult sized at birth and does not
enlarge with age; however, with skull growth, the distance
between the cochlea and the skull increases and may aﬀect
device movement [6].
Programing the cochlear implant in young children is
another challenger. Optimal use of CI technology requires
an accurate assessment of threshold and comfort levels, ob-
tained in older children and adults with behavioral testing.
Aswithdiagnostictesting,behavioralmethodsarefrequently
inappropriate for the very young child [6]. Neural response
telemetry of Cochlear Corporation (Sydney, Australia), neu-
ral response imaging of Advanced Bionics (Valencia, Calif,
USA), and auditory nerve response telemetry of Med-El
(Innsbruk, Austria) use an electrode in each array to record a
response from the auditory nerve. Responses, termed elec-
trically evoked compound action potentials (ECAPs or
EAPs), can be recorded intraoperatively as well as in postop-
erative programming sessions [6].
In very young children, ECAP measurements obtained
throughNRT/NRI/ARThavebeenusedsuccessfullyasabasis
forthreshold(T)andcomfort.In veryyoungchildren,ECAP
measurements obtained through NRT/NRI/ART have been
used successfully as a basis for threshold (T) and comfort (C)
levels in creation of initial speech processor MAPs [6, 19].
Manyauthorshaveprovidedevidenceforlong-termsafe-
ty in the under-1 population.Roland et al. [16], 2009 report-
ed one of the biggest series of young children implanted.
A total of 50 patients implanted under 12 months of age
were followed forupto6.8yearspostoperativelyanddemon-
strated complication rates comparable with those of older
children and adults. The authors reported 16% of compli-
cation andthe predominanceofminor complicationsin very
youngchildren groupisprobablyduetohighlightedissues of
surgical technique, such as the importance of delicate tissue
handling, careful surgical planning, and meticulous treat-
ment of squamous epithelium.
Atthis point itis crucialto bring fordiscussion that CIin
very young children is a safe and eﬀective procedure. There
is growing body of literature supporting improved auditory
and linguistic outcomes in children implanted before 12
months of age [12, 13, 15, 16, 20, 21]. Taken together, early
evidence suggests a higher rate of receptive and language de-
velopment in children implanted under the age of 1. At
present, outcome data in auditory perception and linguistic
development suggest that early implanted children may be
more likely to achieve their full potential and may reduce or
eliminate the need for themto “catch up” orlearn at a faster-
than-normal rate to achieve age-appropriate norms [6].
In conclusion, CI in the very young child provides
unique challenges in diagnosis and certainty of testing, anes-
thetic risk, surgical technique, intraoperative testing and
postoperative programming, long-term safety, development
of receptive and expressive language, and speech perception
outcomes. Overall, research to date support-minimal anes-
thetic,surgical,andlong-termcomplications,suggestingthat
early implantation poses minimal risk to children younger
than 1 yearof age.Beneﬁt in areas ofreceptive and expressive
language development and speech perception has been
suggested by multiple studies.4 International Journal of Otolaryngology
3.CochlearImplant and HearingPreservation
This section will concentrate on research done in attempt to
summarize strategies and results around the world in hear-
ing preservation during cochlear implantation. This attempt
has signiﬁcantly changed the candidacy criteria in the last
years [22]. A number of studies have shown that preserving
residual acoustic hearing in the implanted ear is a realistic
goal for many patients with severe high-frequency hearing
loss. The addition of the electric stimulation to their exist-
ing acoustic hearing can provide enhancement for these pa-
tients. In addition, the preserved acoustic hearing can of-
fer considerable advantages, as compared to a traditional
cochlear implant, for tasks such as word recognition in back-
grounds or appreciation of music and other situations where
the poor-frequency resolution of electric stimulation has
been a disadvantage [22].
Theapproachinvolvespreservingexistingresidualacous-
tic hearing (low-frequency) in an ear to be implanted with a
cochlear implant and then adding electrical stimulation via
thiscochlearimplant forthemissing high frequenciestopro-
duce speech understanding (and other hearing sensations)
via combined acoustic and electric hearing (A + E).
Word recognition research in patients with varying de-
grees of hearing loss by Turner et al. [22] among others sup-
ports the fact that the place of articulation cue is diﬃcult for
most listeners with severe to profound high-frequency hear-
ing loss, since substantial inner hair cell loss prevents the
cochlea from transmitting the frequency cues (presumably
via place coding to the brain conclusions. These regions of
inner hair cell loss referred to as “dead regions”, and, has also
it shown that word recognition is aﬀected. Thus a severe to
profound high-frequency hearing loss often cannot be suc-
cessfully remedied by simple ampliﬁcation [22].
More recently, however, preservation of residual acoustic
hearing in the implanted ear has received attention. Preser-
vation ofhearing within the implanted ear has been reported
in several animal studies from the 1990s. Ni et al. [23]. in
1992foundthatplacementofashortelectrodeinanimalsdid
not induce additional tissue damage distal to the region of
the electrode. Xu et al. [24] in 1997 reported similar results.
Maintenance of near-normal click-evokedABRthresholds in
the majority of cochleae in these studies suggested that hair
cells, at least apical to the implanted electrode array, not only
survive, but also can function at a near normal sensitivity.
Hodges et al. [25] in 1997 reported that one-half of
patients examined following implantation with a cochlear
electrode had at least some behavioral response to acousti-
cally presented tones. Von Ilberg et al. [26] in 1999 report-
ed preservation of hearing in a human patient following
implantation of a standard long-electrode device, and that,
although poor, the residual acoustic hearing was capable of
understanding speech above chance levels. Also in the late
1990s, the group of the University of Iowa began implant-
ing a newly designed cochlear implant with a modiﬁed in-
tracochlear electrode that was much smaller in diameter and
6mm in length, in subjects with usable residual low-fre-
quency hearing. Based on these early reports of preservation
of hearing following implantation, a number of centers have
speciﬁcally attempted to preserve residual hearing in im-
planted ears of their patients.
Some groups have attempted to preserve residual acous-
tic hearing using a standard-length electrode that is partially
inserted into the cochlea, combined with “soft surgery”
techniques designed to minimize trauma. Gstoettner et al.
in 2004 [27] described full or at least partial preservation of
hearing in 18 of 21 patients using this technique. Kiefer et
al. in 2005 [28]r e p o r t e dt h a ta tl e a s tp a r t i a lp r e s e r v a t i o no f
hearing was accomplished in 11 outof 13 patients. The mean
threshold change for those 11 patients was approximately
15dBatthelowerfrequencies,while theremaining 2patients
suﬀered essentially total losses. James et al. in 2005 [29]
reported approximately an average of 25dB loss in the lower
frequencies for 12 patients implanted with a long electrode,
including the data for two patients who suﬀered total losses.
These same authors [29] followed up with additional data,
showing that 10 out of 37 patients initially had residual
hearing preservation immediately following surgery; several
months later, this number had decreased to 7.
Poor-frequency resolution and pitch perception of the
traditional cochlear implant canlead todeﬁcitsinmusicper-
ception. While implant listeners generally are quite good at
perceiving the rhythmic cues in music [22, 27], their recog-
nitionofmelodiesisusuallymuchpoorerthannormal,espe-
cially when therhythmic or lyricalcues are notavailable.The
residual low-frequencyacoustichearing ofA+ Epatientscan
provide assistance in pitch perception in these patients [22].
Gstoettner et al. [27] tested normal hearing traditional
long-electrode, and Hybrid (short-electrode) patients on
melody and instrument recognition and found that Hybrid
patients were nearly as accurate as normals for melody rec-
ognition, whereas the long-electrode patients performed
very poorly. For instrument recognition, the Hybrid patients
did show a deﬁcit compared to normals, but this was
primarily for instruments in the higher-frequency ranges,
where signal was transmitted via the cochlear implant rather
than the acoustic hearing.
The preservation of residual hearing has been shown to
be practical and eﬀective solution for severe high-frequency
hearing loss [22]. It can overcome some of the inherent
disadvantages of traditional, electric-only, long-electrode
cochlear implantation. These advantages of the A + E ap-
proach are primarily a result of the better frequency resolu-
tion provided by the residual hearing as compared to electric
stimulation. Thus the advantages of the A + E approach
are most evident in situations where frequency resolution is
important, such as recognizing speech in backgrounds and
music perception [22].
4.CochlearImplant in UnilateralDeafness
Up to now, treatment modalities of unilateral deafness con-
sist of no treatment, conventional contralateral routing of
signal (CROS), or bone-anchored hearing aid (BAHA) hear-
ing aid. Cochlear implantation makes a new treatment mo-
dality available for patients with single-sided deafness. Arndt
et al. [30] have recently performed a study in eleven adult
subjects with unilateral deafness of various causes. The aimInternational Journal of Otolaryngology 5
was to evaluate the use of unilateral electrical stimulation
with normal hearing on the contralateral side and after a
period of 6 months compared with the preoperative unaided
situation, conventional CROS, or BAHA hearing aids. All
subjects were ﬁtted in random order with a BAHA Intenso
mounted on the soft band/tension clamp or with a CROS
hearing aid. After test periods with both devices, the subjects
received a CI.
The authors found that cochlear implantation improved
hearing abilities in people with single-sided deafness and is
superior to the alternative treatment options. The use of the
CI did not interfere with speech understanding in the nor-
mal-hearing ear. Their data suggested that the binaural inte-
gration of electric and acoustic stimulation is possible even
with unilateral normal hearing.
5.CochlearImplant inUnilateral
Deafness and Tinnitus
Tinnitus is afrequentand oftendebilitatingcondition,which
is diﬃcult to treat. The most frequently used therapies con-
sist of auditory stimulation and cognitive behavioural treat-
ment aiming at improving habituationand copingstrategies.
However, more causally oriented therapeutic strategies are
lacking and need to be developed to relieve auditory per-
ception disturbances. Even though the pathophysiology of
tinnitus remains incompletely understood there is increasing
evidence that tinnitus is related to alterations of neuronal
functioning in the central auditory system. Like phantom
limbpain, tinnitusasan auditoryphantomperceptionseems
to be the correlate of maladaptive attempts of the brain at
reorganization due to distorted sensory input. This notion
is conﬁrmed by the ﬁnding that hearing loss is the most im-
portantriskfactorfordevelopingtinnitusandthatmostpeo-
ple with sudden unilateral deafness experience tinnitus. Ani-
mal experiments have demonstrated that reduced auditory
inputcauses a dysbalance between inhibitory and facilitatory
mechanisms throughout the central auditory pathways,
which then results in reorganization of the tonotopic maps
in the auditory cortex. This might represent a neuronal cor-
relate oftinnitus[31].Accordinglytherapeuticstrategies that
either speciﬁcally compensate for hearing loss or normalize
auditory input (e.g., hearing aids) have been shown to con-
sistently attenuate tinnitus complaints [32].
In subjects who are deaf and who also have tinnitus in
the aﬀected ear, tinnitus treatments based on acoustic input
are impossible. On the other hand, tinnitus suppression us-
ing electric stimulation has been reported to be successful.
Buechner et al. [33] have initiated a study in order to investi-
gate the potential of cochlear implantation (CI) in unilateral
deaf subjects regarding tinnitus suppression, device accept-
ance, and restoration of spatial hearing. They studied ﬁve
subjects with severe to profound unilateral deafness having
also ipsilateral tinnitus. In monthly visits, the speech pro-
cessor program was optimized, and the hearing performance
as well as tinnitus was monitored. In addition, it was inves-
tigated whether the CI improves hearing in adverse listening
situations when combined with the normal hearing side.
In 3 participants, the tinnitus was signiﬁcantly sup-
pressed while wearing the device. In the other 2 participants,
the tinnitus could be reduced in certain situations. Speech
perception tests revealed a signiﬁcant beneﬁt with the CI in
combinationwiththenormal-hearing sidefor3participants.
All participants accepted the device in a clinical setting;
adaptation of the frequency allocation was not required.
They concluded that improvements were found regarding
the hearing and the tinnitus. Not all participants beneﬁt
from the CI to the same degree and in the same situations.
The results indicate that cochlear implantation in subjects
with unilateralseveretoprofoundhearinglossandipsilateral
tinnitus may be beneﬁcial on a case-to-case basis. However,
furtherwork needstobeperformed todeﬁnetheappropriate
indication criteria for selection of patients with unilateral
deafness.
Kleinjung and colleagues [34] reported a case of a
55-year-old man suﬀering from severe right-sided tinnitus
in consequence of sudden right-sided deafness. Multiple
therapeutic eﬀorts including intravenous steroids and tym-
panoscopy with grafting of the round window remained
unsuccessful. One year after onset of symptoms, right-sided
cochlear implantation was performed, which resulted in a
complete abolishment of tinnitus after activating the im-
plant. The authors posted that severe unilateral tinnitus after
sudden deafness might represent a new indication for coch-
lear implantation
The application of cochlear implants for tinnitus relief in
patients with unilateral deafness has so far been described in
another study [35]. All21 patients includedin thatstudy had
unilateral sensorineural hearing loss accompanied by severe
tinnitus for at least two years. In 95% of patients beneﬁ-
cial eﬀects could be demonstrated. Three patients showed
complete tinnitus relief, whereas the majority demonstrated
statistically signiﬁcant improvement on tinnitus loudness
and impact.
According to diﬀerent pathologic changes that generate
neural activity interpreted as tinnitus, thereare several possi-
ble mechanisms which may account for tinnitus suppression
after cochlear implantation. Some reports further support
the model of tinnitus pathophysiology, in which chronic
tinnitus as an auditory phantom perception might be the
correlate of maladaptive attempts at cortical reorganization
due to peripheral deaﬀerentation [36]. As a consequence
of this theory, restoration of peripheral sensory input may
have long-term beneﬁcial eﬀects on tinnitus by plastic reor-
ganization of the central auditory nervous system. Such a
mechanism might be reﬂected by the observed time course
in some patients where tinnitus improved over a period of
about three months after implantation. Another possible
explanation for the positive eﬀect might be the masking of
tinnitus following increased auditory information due to the
cochlear implant.
Residual inhibition might explain tinnitus suppression
eﬀects which outlast the active stimulation period for a cer-
tain amount of time. But some observation that tinnitus was
neither perceived in quiet environments nor during sleep
might not entirely account for this theory. The eﬀect of the
insertion of the electrode into the cochlear should also be6 International Journal of Otolaryngology
discussed [36]. Cochlear implantation causes immediate and
subsequent trauma to remaining cochlear structures. This
might be of beneﬁt in patients, in which abnormal activity
of hair cells turns out to be a constant trigger mechanism for
tinnitus. However, in these patientsimmediate postoperative
eﬀects due to destruction should be expected, which might
occur independent of activation of the implant system.
In summary, disabling tinnitus resulting from sudden
unilateral deafness should be considered as a new indication
for a cochlear implant procedure. As demonstrated in this
report and supported bythe literaturedata,cochlearimplan-
tation may represent a chance for complete suppression of
tinnitus in selected patients.
6.GeneticHearingLossandCochlearImplant
The hereditary causes are responsible by greater than 60%
ofall prelingually deafened with environmental oriatrogenic
causes responsible by the remaining 40% [37]. Some ofthem
will have good performance with ampliﬁcation, but a sub-
stantial number of patients will need cochlear implantation.
The literature has been not so clear about the success of
cochlear implantation in genetic hearing loss, because some
series are composed by small number of patients.
6.1. Connexin 26 and 30. Connexin 26 (Cx26) mutation
has been reported to cause 50% of cases of nonsyndromic
autosomal recessive hearing l o s sw h i c hm a k e st h i sd i s o r d e r
themostcommoncauseofnonsyndromichereditaryhearing
loss. Dominant Cx26 mutations have been associated with
syndromic disease with skin disorders such as keratitis ich-
thyosis deafness syndrome and palmoplantar keratoderma
with deafness, and they are rare [38].
The connexins are proteins. Six containes assemble to
formhalfachannelorconnexonandtwoconnexonstogether
create an intracellular gap junction channel involved in elec-
trolytetransportation keepingthepotassiumgradientwithin
the spiral ligament and stria vascularis and communication
between cells too. When these proteins present a defect may,
occur potassium accumulation, and lack of recirculation is
presumed to lead to hair cell dysfunction and degeneration
[39]. Another role has been suggested for the Cx26 channels,
sotheymayberesponsible forcalciummobilizationinvolved
in cochlear physiology regulation. One of the most common
mutation, for Cx26 is the 30delG, also known as 35delG
because the deletion can occur anywhere within a stretch of
six consecutive Gs [40], despite of the identiﬁcation of more
than 100 mutations for Cx26. A temporal bone analysis of a
heterozygousCx26mutationdemonstratedintact spiralgan-
glion cells, no neural degeneration, absence of hair cells in
the organ of Corti, and agenesis of the stria vascularis [41],
whichmayexplaingoodperformance aftercochlearimplants
in these patients, since they have greater neural integrity of
peripheral and central auditory systems [41, 42]. A study
with the majority of patients being homozygous for 35delG
showed better speech and language ability after cochlear
implantation [43].
6.2. Usher Syndrome. Usher syndrome is one of the most
common cause of deaf blindness in humans [44], and it is an
autosomal recessive syndromic hearing loss characterized by
sensory impairment of ears and eyes, which results in con-
genital sensorineural hearing loss with progressive retinitis
pigmentosa, and posteriorly, retina degeneration, loss of
night vision after 10 years of age, restriction of visual ﬁeld
and sometimes blindness in adolescence.
The literature describes three types of the Usher syn-
d r o m e .T h et y p eI( U S H 1 )i st h em o s ts e v e r ef o r mo ft h e
Usher syndrome and well discussed, accounting for 30–40%
and it is characterized by severeto profound congenitalhear-
ing loss, motor development delay in children, and progres-
sive retinopathy with vision loss, decreased peripheralvision,
and central acuity in the ﬁrst decade of life leading to blind-
ness by young adulthood. Molecular studies have shown
that the defective proteins are located within the devel-
oping auditory hair bundle, either within the stereocilia
or kinocilium. The defective proteins in USH1—myosin
VIIa, PDZ-domaincontaining protein harmonin, cadherin
23, protocadherin 15, and the scaﬀolding protein Sans—
are hypothesized to be associated with hair bundle-linked-
mediated adhesion forces [45].
In temporal bone examination from USH1 patients, se-
vere degeneration primarily of the basal turn of the organ
of Corti, atrophy of the stria vascularis, and a decrease in
spiral ganglion cells were found. The cochlear neurons were
diminished with an average of 68% neuronal loss compared
with age-matched controls [45]. Patients have low-frequency
residualhearingandlittlebeneﬁtfromampliﬁcationsococh-
lear implantation is done as soon as possible because vision
impairment makes sign language a temporary solution. Liu
et al. [46] and of Blanchet et al. [47, 48] concluded that
early implantation is critical to developing eﬀective oral-
auditory skills prior to visual loss, so the best results are seen
in children implanted before 3 years of age. The best pro-
gnostic factor after cochlear implants seems to be the age
implantation and not genotypic mutations. Other beneﬁts
of cochlear implantation like better quality of life and in-
dependent living are also well described [49].
6.3.Mitochondrial Disorders. Mitochondrial DNA(MtDNA)
mutations are maternally inherited predominantly, because
mitochondria are located at the cytoplasm, and the fertilized
embryo receives almost only the ovum cytoplasm. The mito-
chondria is involved in adenosine triphosphate (ATP) pro-
duction through oxidative phosphorylation process that is
criticalespeciallyforthoseorganswithhighmetabolicneeds.
At the inner ear outer hair cells and the stria vascularis have
high ATP demands. The hair cells rely on an appropriate
endocochlear potential produced by the stria vascularis and
its many Na+ K+ ATP pumps. It is hypothesized that mito-
chondrial dysfunction resultsin ionicimbalances, cell injury,
and then death with concomitant hearing loss. The basal
aspectofthecochlea,which isresponsible forhigh-frequency
hearing, requires evengreater metabolic support. As a result,
e a r l yi n j u r yt ot h i sa r e al i k ei na m i n o g l y c o s i d eo t o t o x i c i t yo r
noise exposure results in the classical high-frequency hearing
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progresses to aﬀect other areas of the cochlea [50, 51], and
at temporal bone studies it is possible to see decreased con-
centration of intact spiral ganglion cells, greater injury to
outer hair cells versus inner hair cells, and progression of
dysfunction from the basal aspect of the cochlea to the apex
[52, 53].
Since sensorineural hearing loss (SNHL)is found in 42%
to70%ofpatientswithmitochondrialdisordersandcochlear
implants are the treatment choice for a large number of
them, it becomes relevant to look at this disease group. In
these patients hearing loss is classiﬁed as syndromic: mito-
chondrial encephalopathy,lactic acidosis and stroke-likeepi-
sodes(MELASsyndrome), maternally inheriteddiabetesand
deafness(MIDDsyndrome),theKearns-Sayre syndromeand
chronic progressive external ophthalmoplegia (CPEO) and
nonsyndromic. The nonsyndromic SNHL is associated with
ototoxic side eﬀect of aminoglycoside antibiotics and the
predominant mutation at maternally inherited MtDNA is
A1555G in more than 50% of patients that present SNHL
after aminoglycoside use. SNHL occurring in patients with
the A1555G mutation without aminoglycosides exposure is
reported, but it is milder. Residual hearing is found in pa-
tients with A1555G mutation associated with lower thresh-
olds for electric promontory stimulation that suggests spiral
ganglion cell preservation, making them good candidates for
cochlear implants.
Usami et al. [54] related 14 cochlear implantees with
A1555G mutation of them 13 had previous exposition to
aminoglycosides and from all the patients with ototoxicity
history that received cochlear implants 59% had A1555G
mutation. Considering syndromic group, SNHL is found in
50% of MELAS patients, and A3243G mutation is respon-
sible for about 80% of MELAS cases. The epidemiology of
the A3243G mutation reveals a frequency of 16.3/100,000 in
the general adult population. Cochlear implants in MELAS
patients have been successful in treating SNHL A3243G
mutation patients [55]. It is interesting to notice that MIDD
can arise from the same mutation, but the phenotype is nar-
rower. The SNHL presented by MIDD patients has been
overcome successfully by cochlear implantation too. The
Kearns-Sayre syndrome is a rare multisystem disorder in
which we can see a slowly progressive disorder involving
paralysis of the levator palpebrae, orbicularis oculi, and ex-
traocular muscles and SNHL in at least 60% of KSS cases.
The A3243G mtDNAmutation, as well as more common
large-scale deletions, has been found responsible in skeletal
muscle biopsy specimens, and these are usually of sporadic
origin in both KSS and CPEO [56], and both of them have
showed good results with cochlear implantation [57, 58].
Othermutations or syndromes related tomitochondrial syn-
dromic SNHL have no cochlear implants reported.
6.4. The Waardedenburg Syndrome. Waardenburg syndrome
(WS) is an autosomal syndrome characterized by dystopia
canthorum, hyperplasia of the eyebrows, heterochromia
iridis, a white forelock, and variable sensorineural hearing
loss present in 1 in 40,000 live births and responsible
by 2–5% of all congenitally deafened children [59]. Four
fenotypes are described as follows: type 1 (dystopia can-
thorum, sensorineural hearing loss, heterochromia iridis,
white forelock, hypopigmentation, synophrys), type 2 (type
1 features without dystopia canthorum), type 3 or the Klein-
Waardenburg syndrome (type 1 features plus hypoplastic
muscles and contracture of the upper limbs), and type 4 or
the Shah-Waardenburg syndrome (type 2 features associated
with Hirschsprung’s disease) [59]. In WS1 melanogenesis is
aﬀected by the action of PAX3 gene, a transcription factor.
Absence of melanocytes aﬀects pigmentation of the hair,
skin, andeyesas well as theneuralcrestcellsthatmigrateand
formthebasisofthestriavascularis[60,61].Hearinglosshas
been noted in 35–75% of patients with WS1 and 55–91% of
patients with WS II and may be due to lack of melanocyte
pigmentation in the stria vascularis of the cochlea [61].
Temporal bone studies of WS patients have shown atrophy
of the organ of Corti and the stria vascularis [61]. Treatment
may involve ampliﬁcation and cochlear implantation for
profound sensorineural hearing loss. Studies of WS cochlear
implantshavedemonstratedwellperformance inbothclosed
andopen-setword standardized tests[62,63].Itisimportant
to remember the increased incidence of auditory neuropathy
in this patient population, which may undermine implant
eﬃcacy [64].
6.5. The Jervell and Lange-Nielsen Syndrome. The Jervel
Lange-Nielsen syndrome (JLNS) is characterized by a con-
stellation ofsyncope, suddendeath, congenital sensorineural
deafness, and cardiac arrhythmias like signiﬁcant brady-
cardia, ventricular tachycardia, ventricular ﬁbrillation, and
torsadesdespoints,whichleadstosyncopeandsuddendeath
if not treated [65]. 95% of these attacks were triggered by
emotional stress, exercise, or loud noise, with sympathetic
activation as a unifying theme. Genetic defect is located
in the KCNQ1 and KCNE1 (LQT1) genes that form the
slow component of the delayed rectiﬁer potassium channel
complex (90 and 10% of cases, resp.).
This mechanism is responsible by endolymph potassium
maintenance at the stria vascularis and ventricular repo-
larization by moving potassium ions out of the cell [66,
67]. Scala media and endolymphatic compartments of the
vestibular end organs are found obliterated by the collapse
of Reissner’s membrane and membranes surrounding the
saccule, utricle, and ampullae [68]. There are small series
describing good results in auditory performance and speech
intelligibility rating after cochlear implantation [69, 70], and
all agree that with appropriate precautions regarding cardiac
disorders, cochlear implantation may be performed safely in
patients with JLNS allowing for improved audition.
7.Bilateral CochlearImplant
Our auditory environments are noisy and full of multiple
sound sources that are a challenge for auditory system. The
binaural system is responsible for providing cues that segre-
gate target signals from competing sounds, and it is able to
identify sound sources in normal hearing listeners. Binaural
hearing is the result of integration between inputs from the
two ears and auditory pathways. The consequence of bin-
aural hearing is the speech understanding when competing8 International Journal of Otolaryngology
sounds are present, and it is well known that when listening
with only one ear, sound localization becomes very diﬃcult
to achieve. Three primary eﬀects on perception have been
identiﬁed in binaural hearing: the head shadow eﬀect, the
binaural summation eﬀect, and the binaural squelch eﬀect
[71].
The head shadow eﬀect occurs during everyday listening
conditions when speech and noise are spatially separated.
For example, background noise coming from the right side
would interfere with the right ear but the head would block
(create an acoustic shadow) some of the interfering noise
from reaching the left ear. Thus, the head shadow eﬀect
would result in a better signal-to-noise ratio (SNR) in the
protected left ear [72]. A listener is able to selectively attend
to the ear with the better SNR to improve intelligibility.
The head shadow attenuates high-frequency sounds by
approximately 20dB but low frequency by only 3–6dB [73],
and this eﬀect does not require central auditory processing.
The head shadow eﬀect has the largest impact on
hearing with binaural cochlear implantation. The binaural
squelcheﬀectalso operateswhen competing noise isspatially
separate from the signal so that the two ears receive diﬀerent
inputs. Unlike the purely physical head shadow, however,
squelch requires central auditory processing that integrates
the signals from each ear so that the auditory cortex receives
a better signal than could be possible from either ear alone
[74]. The brainstem auditory nuclei process diﬀerences in
timing, amplitude and spectral signals coming from the two
ears, resulting in improved separation of speech and noise.
Evidenceofbeneﬁtofthebinauralsquelcheﬀectissomewhat
limited, not seen in all users, and is not as large as seen with
the head shadow eﬀect [72].
Binaural summation also refers to a central processing
eﬀect,butit is thoughttooccurwhen bothears are presented
with asimilar signal. The combinedsignals from thetwo ears
are perceived as louder by up to 3dB compared with mon-
aural listening to the same signal [75]. This doubling of
perceptual loudness is accompanied by increased sensitivity
to diﬀerences in intensity and frequency and can lead to im-
provements in speech intelligibility under both quiet con-
ditionsand when exposed to noise. The literature in this area
is limited, and the beneﬁt is not as great as the head shadow
eﬀect [72].
Considering the advent of cochlear implantation and
the great beneﬁts experienced by users, it is important to
stress its limitations, some of them from the device itself
and other ones associated to monoaural hearing. The unilat-
eral cochlear implant user shows poor ability in sound
source identiﬁcation, and it could be diﬃcult hearing speech
in noisy environment, so if the bilateral cochlear implant
recipients are able to utilize the eﬀects described above,
this ultimately determines the degree of additional beneﬁt a
second implant will provide.
The literature now containes huge series of bilateral
cochlear implantation, and authors reported the ability of
bilateral CI users to hear speech in the presence of com-
peting stimuli and they have advantage of spatial separation
between target and competing speech [75–77]. A common
ﬁnding ofthese studieswas thatbinaural advantage occurred
to a greater extent under noisy conditions than in a quiet
environmentwith abetterspeech intelligibility,mostofitbe-
cause of head shadow eﬀect. In a study conducted with 17
native English-speaking adults presenting postlingual deaf-
ness that received the same implant model (Nucleus 24
Contour implant) in both ears, either during the same sur-
gery or during two separate surgeries, the authors found
speech intelligibility improvement with one versus two im-
plants improve with time, in particular when spatial cues are
used to segregate speech and competing noise.
Localization and speech-in-noise abilities in this group
of patients are somewhat correlated [78]. In bilaterally im-
planted children, there is signiﬁcant increase in speech dis-
crimination when the authors compared bilateral implants
with the best-performing unilateral implant [79, 80]. The
William House group in the annual meeting at the Septem-
ber 15, 2007 Cochlear Implant Study Group (CISG) dis-
cussed the issue of bilateral implantation with about 250 CI
professionals.
The specialists were concerned about unilateral cochlear
implanted diﬃculties in everydaylistening conditions. Func-
tional localization of sounds is not possible with only 1
implant, often creating a safety issue, and hearing in noise is
very diﬃcult. They consider bilateral cochlear implantation
advisable based on the results of improved speech intelli-
gibility and sound localization and the expansion of the
receptive sound ﬁeld. Finally they agree that both children
and adult may have better auditory performance with bilat-
eral implants compared with unilateral ones [81].
Bilateral cochlear implants may not be an option or
recommended for all adult recipients. This could be due to
health issues that prevent a second surgery, lack of insurance
coverage, or, in many cases, a notable amount of residual
hearing in the nonimplanted ear. In these cases, the use of a
hearing aid in the nonimplanted ear can represent a viable,
aﬀordable, and potentially beneﬁcial option for bilateral
stimulation despite the asymmetry in hearing between ears.
This asymmetry occurs because the type of auditory
input received by the two ears is quite diﬀerent. The cochlear
implant provides electric stimulation, while the hearing aid
provides acoustic stimulation, which in combination across
the ears is likely to provide atypical interaural diﬀerence cues
in time and level[82].Performance in the bimodalcondition
was signiﬁcantly better for word recognition and localization
compared to the cochlear-implant only and hearing-aid only
conditions as the authors could observe studying 19 adult
patientswhich wereimplantedwithCochlearNucleus24and
worn Widex Senso Vita 38 hearing aid at the other ear [82].
7.1. Sequential or Simultaneous Bilateral Cochlear Implant?
When considering the best moment to do the second
implant, surgeons should inform patients about the same
risks from the ﬁrst operation and that the additional beneﬁts
with the second one may be not so great (it only increases
around 20%) [72]. This way, it seems that simultaneous
than sequential binaural implantation is advisable due to
avoidance of a second hospitalization and general anesthetic,
and it will be possible to use the same processor for both
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cochlear implants (CIs), development of normal patterns of
cortical activity occurs when interimplant delays are mini-
mized.
Gordon et al. [84] have examined data suggesting that
after 3 to 4 years of bilateral CI use, normal-like patterns of
bilateral cortical activity are promoted in children receiving
bilateral CI with minimal interimplant delays and young
ages but are not present in older children who had longer
interimplant delays. The optimal binaural hearing has not
been achieved yet with bilateral implants, probably because
the processing strategies in use. Then some studies havebeen
suggesting that separated processors may produce interaural
cues that are inappropriate for the actual sound source, and
the probable solution is the use of only one processor or
coordinate processors.
8.Neuropathyand CochlearImplant
Auditory neuropathy/dyssynchrony (AN/AD) is a form of
hearing impairment characterized by moderate-to-profound
sensorineural hearing loss, progressive or transient, in which
function outer cells is preserved, but aﬀerent neural activity
in the auditory nerve and central auditory pathways is disor-
dered [85]. The incidence of AN has been estimated as 10%
to 14% of children diagnosed with severe to profound SNHL
[85]. In the audiological evaluation, otoacoustic emission
responses can be showing normal preneural cochlear activity
found but evoked response from the auditory pathway is
commonly absent. Cochlear microphonic responses (pro-
duced by polarization and depolarization of cochlear outer
hair cells) are also presented.
The auditory pathway disorder is suggested by the ab-
senceorsever edistortionofelectricpotentialsfr omtheaudi-
tory nerve (compound action potential) and auditory brain-
stem response (ABR) [86]. There are some hypotheses to ex-
plain AN/AD that might be produced by lesion in the
cochlear inner hair cells, at the synapse between these cells
and the Type1 auditory nerve ﬁbers, and in the auditory
nerve itself [85, 87]. Clinically patients present speech dis-
crimination scores worse than predicted by pure tone au-
diologywithpoorresponse tohearingaidampliﬁcation[88].
TheincidenceofANhasbeenestimatedas10%to14%of
children diagnosed with severe to profound SNHL [89]. The
natural history may be progressive or transient. Even in cases
ofmild hearing loss, those with prelingual onset often do not
develop speech [87]. Hearing aids in these cases are rarely
beneﬁcial. However, cochlear implants are debated because
if the site of lesion is the cochlea, then bypassing the inner
hair cells with direct stimulation of the VIIIth cranial nerve
should produce good results, but if the pathologic condition
lies in the nerve itself, such as demyelinization of the VIIIth
cranial nerve, then electrical stimulation might be expected
to be subject to the same limitations as acoustic stimulation.
Considering this second possibility, many clinicians have
been very conservative about cochlear implantation as an
option for auditory neuropathy. Buss et al. [90] reported re-
sults for 4 children with AN who had postimplant speech
data comparable with the general pediatric population re-
ceiving implants.
The Sydney Cochlear Implant Centre (SCIC) has one of
the largest cohorts of pediatric patients with AN undergoing
cochlear implantation in the world (n = 80). Many of the
children have proceeded to successful implantation, with a
smaller number failing to gain signiﬁcant beneﬁt [91]. Gib-
sonandGraham [92]publishedaneditorialaboutthistheme
in 2008 where they recommend ﬁrst of all a detailed inves-
tigation of auditory neuropathy patients including electroc-
ochleography, auditory brainstem responses, and electrically
evokedauditorybrainstemresponses, togetherwithimaging,
in order to identify the site of the underlying pathological
conditions that may produce the combination of otoacoustic
emissions in the absence of auditory brainstem responses in
children with hearing loss. Itis suggested that in 75%ofcases
auditoryneuropathycanmerelybearesultofsurvivingouter
hair cells when inner hair cell function is compromised.
The remaining cases of auditory neuropathy may have
dysfunction of the aﬀerent neural synapse, cochlear nerve,
cochlear nucleus, auditory brainstem tracts, and central au-
ditory system. They concluded that each case must be seen
individually ratherthan continuing to usea misleading term.
Teagle et al. [93] related the results of cochlear implantation
in 37% of 140 children with AN diagnosis. Although 50%
of the implanted children with AN demonstrated open-set
speech perception abilities after implantation, nearly 30% of
them with >6 months of implant experience were unable
to participate in this type of testing because of their young
age or developmental delays. No child with cochlear nerve
deﬁciency (CND) in their implanted ear achieved open-
set speech perception abilities. In a subgroup of children,
good open-set speech perception skills were associated with
robust responses elicited on electrically evoked intracochlear
compound action potential testing when this assessment was
possible.
Theauthorssuggestthatvariableperformanceaftercoch-
lear implantation observed here may be explained by a wide
variety of impairments. Some children will not achieve ben-
eﬁt from implantation, probably because of a lack of elec-
trically induced neural synchronization, the detrimental ef-
fects of their other associated conditions, or a combination
of factors. Teagle et al. [93] considered the ﬁnding of central
nervous system pathology at preoperative magnetic reso-
nance imaging a poor prognosis for the development of
open-set speech perception, particularly when CND is
evident. During patient selection electrically evoked intrac-
ochlear compound action potential testing may help identify
those children who will develop good open-set speech per-
ception. Instead of recommending CI for all children with
electrophysiologic evidence of ANSD, the stepwise manage-
mentproceduredescribedhereinallowsfortheidentiﬁcation
of children who may beneﬁt from ampliﬁcation, those who
are appropriate candidates for cochlear implantation, and
those who, because ofbilateral CND,may not be appropriate
candidates for either intervention. Auditory neuropathy is a
complex multifactorial condition encompassing a spectrum
of clinical syndromes and outcomes with cochlear implanta-
tion.10 International Journal of Otolaryngology
It is common to ﬁnd varied and diverse conditions as-
sociatedwithANlikeprematurity,hyperbilirubinemia,other
metabolic and genetic disorders, and infections, which may
result in a range of clinical presentation from mild to pro-
found SNHL associated with normal or abnormal inner ear
structures and vestibulocochlear nerves [94].
9.NeuralPlasticityand theSelectionof
P atientsforCoc hlearI mplant
A study using functional magnetic resonance imaging
(fMRI) [95] was conducted to examine the eﬀects of deaf-
ness, age of language acquisition, and bilingualism by com-
paring results from normally hearing, monolingual native
speakers, congenitally deaf signers of American Sign Lan-
guage (ASL), and normally hearing, bilingual speakers who
were native signers of ASL and speakers of English. In this
comprehensive examination, a strong and repeated activa-
tion of the classical language areas of the left hemisphere
wasobservedinnormal hearing and deafsubjects,while pro-
cessing their native language, English, or ASL. However, deaf
subjects reading English did not display activation in these
regions. These results suggest that the early acquisition of a
natural language is important in the expression of the strong
bias for these areas to mediate language, independently of
the form of language. In addition, native signers—hearing
or deaf—displayed extensive activation of homologous areas
within the right hemisphere, indicating that the speciﬁc
processing requirements of the language may also, in part,
determine the organization of the language systems of the
brain and support the hypothesis that the delayed and/or
imperfect acquisition of a language leads to an anomalous
pattern of brain organization for that language.
The removal or inactivation of cochlear hair cells leads
to an immediate loss of activity in the auditory nerve [96].
The structural and functional consequences in the central
auditory system are strongly dependent on the age at which
inner hair cell (IHC) inactivation or other deaﬀerentation
occurred, the time since inactivation, and the level of the
auditory system [97]. In mammals, when the inactivation
occurs before the onset of functional hearing, 50–90% of
cochlear nucleus neurons will die within days of the inac-
tivation [98]. Further substantial neuron loss occurs up-
stream, in the nuclei of the superior olivary complex [99].
However, just before the onset of hearing, IHC-inactivation
dependent brainstem neuron death abruptly declines, sug-
gesting a mechanism that is linked to the initiation of audi-
tory function [98] and for which cellular and molecular
mechanisms continue to be sought [100].
Physiologically, neurons that normally only receive exci-
tation from a deafened ear become inactive following IHC
inactivation at any age, but, paradoxically, those in other
parts of the auditory system become hyperexcitable [101],
a response that has attracted interest as a possible mecha-
nism of tinnitus [102]. Partial lesions of one cochlea in
adults result in a spreading cortical representation of sound
frequencies originating from the undamaged portion of
the cochlea [103]. Electrical stimulation may protect the
developingauditorysystemfromdegeneration[104]because
degenerativeeﬀectsthatfollowIHCinactivation aftertheon-
set of hearing have been linked to the loss of aﬀerent activity
in the auditory nerve [105].
It is well known that auditory perception of cochlear im-
plant users gradually improves after post-surgical activation,
andthisimprovementoccurswithvariableextentindiﬀerent
age groups, overdiﬀerenttime courses, and fordiﬀerentout-
come measures [106]. The literature has demonstrated that
in terms ofspeech developmentand language acquisitionthe
best results come from children implanted under the age of
2 years very similar to normal-hearing children. However,
the capacity for plasticity in adult sensory systems, given
appropriate patterns of behaviourally signiﬁcant input, has
more recently become generally accepted [107].
10.Conclusions
In recent years the indication criteria for cochlear implan-
tation (CI) have changed. To gain optimal beneﬁts, early
implantation in prelingually deaf children is necessary. Even
additional disabilities are no longer contraindications for
CI. Nowadays the criteria for implantation not only include
deafness but also residual hearing. Combined electric-acous-
tic stimulation has been established as a treatment option in
patients withhearing still functioning in the lowfrequencies.
Due to the beneﬁts of binaural hearing, bilateral CI has be-
come standard over the last decade. Recent experience has
shown the beneﬁts of CI in unilateral deafness and in cases
of severe tinnitus. The actual beneﬁt of CI shows great inter-
individual diﬀerences. We usually expect (re-)habilitation of
language communication skills with implantation.
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